Trump announces reforms to accelerate access to psychedelic drug treatments
Quick Insights
The Bottom Line
President Trump signed an executive order to expedite FDA review of psychedelic drugs for treatment.
How This Affects You
This could speed up medical research and treatment options for conditions like PTSD, potentially making drugs like ibogaine available sooner.
AI Summary
President Donald Trump signed an executive order on Saturday to accelerate access to psychedelic drug treatments. The order specifically directs the federal Food and Drug Administration (FDA) to expedite its review process for psychedelic drugs, including ibogaine. This action aims to speed up medical research and treatment options for conditions like post-traumatic stress disorder (PTSD). US military veteran groups have advocated for ibogaine, citing its potential to treat PTSD. The Trump administration's move could significantly alter the regulatory landscape for these substances.
What's Being Done
President Trump signed an executive order directing the FDA to expedite its review process for psychedelic drugs.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. 'Let's do it' - Fortune
Trump announces reforms to accelerate access to psychedelic drug treatments - The Guardian
Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine
This article is part of a story we're tracking:
Trump Administration's Push for Psychedelic Drug Treatments
President Donald Trump has signed an executive order to accelerate access to and research into psychedelic drug treatments. This move aims to expand the availability of substances like LSD, psilocybin, and ibogaine for mental health treatment and research.
Trump Administration's Psychedelic Drug Initiative
President Trump signed an executive order to accelerate access to psychedelic drug treatments and research for mental health. This initiative aims to expand the availability of substances like LSD, psilocybin, and ibogaine for medical use.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.
Trump's Psychedelics Research Initiative
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order aimed at accelerating the federal review process for psychedelics. The order seeks to expand access to psychedelic drug treatments for mental health, specifically mentioning substances like ibogaine, LSD, and psilocybin.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump has signed an executive order to fast-track the review and research of psychedelic drugs for mental health disorders. This move aims to accelerate access to treatments like psilocybin and ibogaine, with the President publicly endorsing their potential.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump signed an executive order to accelerate research and review of psychedelic drugs like psilocybin and ibogaine for mental health treatments. This move aims to fast-track their potential medical applications, with figures like Joe Rogan joining the announcement.
Trump Administration's Psychedelic Drug Research Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.
Trump Executive Order on Psychedelic Drug Research
President Trump signed an executive order to accelerate research and access to psychedelic drug treatments for mental health disorders. The initiative aims to fast-track the review process for substances like psilocybin and ibogaine.
US Political Figures and Psychedelic Drug Research
President Trump has signed an executive order to accelerate research and ease restrictions on psychedelic drug treatments for mental health disorders. This move has drawn attention from various political figures and media outlets, including podcaster Joe Rogan.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthFDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
PoliticsWhat to Know About Trump’s New Executive Order on Psychedelic Drugs
The order calls for the FDA to give expedited consideration to certain psychedelic drugs.
PoliticsWatch live: Trump signs executive order from White House
President Trump will sign an executive order centered on medical research from the White House on Saturday morning. The event comes a day after Trump gave remarks in Phoenix focused on his agenda and courting voters ahead of the midterms, garnering the president a standing ovation. It also comes after the administration unveiled its fiscal…
HealthReport: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
Despite the president’s plan to lower prescription medicine costs, the price of many of the most expensive drugs — including several immunotherapy treatments — have continued to rise.
PoliticsPresident Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans - The White House (.gov)
PoliticsFACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don't show that - AP News
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPN0hCS3FkWU9qY3ZET3l2WjVnTTZhYXFxWnFWZ2dGMU0yYno3akxuRG9BMmdIdVltMVAyNXRrNVpkR2RhcFo4OVp6MzY2clFYV0JLRlpMSUNDN3lzMlgwWVdmR2VFemd3NXJSX3dsWU9Eam9BMHVFWjBOeF9EV3JkVE1aRUJzSFFtME1JZHlRSkVKYzJpZG5lY19MQ25pa01lbDBXTnpB?oc=5" target="_blank">FACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don't show that</a> <font color="#6f6f6f">AP News</font>
Trump labor secretary Lori Chavez-DeRemer resigns amid misconduct investigation - The Guardian
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
4/14: The Takeout with Major Garrett
Trump’s Memphis Crime Task Force Arrested Over 800 Immigrants, Records Show. Only 2% of the Arrests Were for Violent Crimes.
Bipartisan duo that pushed Swalwell, Gonzales to resign says other lawmakers may be next
White House ramps up pressure to pass crypto bill as Congress returns
